Paper4334089
1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors.
Wilson CB and 2 others. Cancer Chemother Rep, 1970. Cited by 172 papers, by iCite.
Cite this record
ConductScience Library. 1,3-bis (2-chloroethyl)-1-nitrosourea (NSC-409962) in the treatment of brain tumors. Papers, record 4334089. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4334089
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics23
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Astrocytoma | Major topic |
| Brain Neoplasms | Major topic |
| Glioblastoma | Major topic |
| Nitroso Compounds | Major topic |
| Urea | Major topic |
| Adenocarcinoma | |
| Adolescent | |
| Chordoma | |
| Clinical Trials as Topic | |
| Ependymoma | |
| Glioma | |
| Humans | |
| Hyperemia | |
| Male | |
| Medulloblastoma | |
| Melanoma | |
| Middle Aged | |
| Nausea | |
| Nitrosourea Compounds | |
| Phlebitis | |
| Radiotherapy | |
| Vomiting |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 172 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35446393 | Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research. | J Neuropathol Exp Neurol | 2022 | https://conductscience.org/library/papers/35446393 | PubMed |
| 34944933 | Pediatric versus Adult Medulloblastoma: Towards a Definition That Goes beyond Age. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34944933 | PubMed |
| 19344302 | Design and application of oncolytic HSV vectors for glioblastoma therapy. | Expert Rev Neurother | 2009 | https://conductscience.org/library/papers/19344302 | PubMed |
| 18813876 | What is the translational efficacy of chemotherapeutic drug research in neuro-oncology? A systematic review and meta-analysis of the efficacy of BCNU and CCNU in animal models of glioma. | J Neurooncol | 2009 | https://conductscience.org/library/papers/18813876 | PubMed |
| 12777076 | Formation of DNA adducts and tumor growth delay following intratumoral administration of DTI-015. | J Neurooncol | 2003 | https://conductscience.org/library/papers/12777076 | PubMed |
| 10780513 | Chemotherapy for high-grade gliomas. | Br J Cancer | 2000 | https://conductscience.org/library/papers/10780513 | PubMed |
| 7807189 | The basis for current treatment recommendations for malignant gliomas. | J Neurooncol | 1994 | https://conductscience.org/library/papers/7807189 | PubMed |
| 6678305 | A phase II trial of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea (PCNU, NSC 95466) in recurrent malignant brain tumors. | J Neurooncol | 1983 | https://conductscience.org/library/papers/6678305 | PubMed |
| 6289164 | Measurements of the volume and density of intracerebral tumors by CT following therapy. | Neuroradiology | 1982 | https://conductscience.org/library/papers/6289164 | PubMed |
| 6088725 | Treatment of malignant gliomas in adults with BCNU plus metronidazole. | J Neurooncol | 1984 | https://conductscience.org/library/papers/6088725 | PubMed |
| 6088718 | High dose BCNU with autologous bone marrow rescue in the treatment of recurrent malignant gliomas. | J Neurooncol | 1983 | https://conductscience.org/library/papers/6088718 | PubMed |
| 4085418 | Repair of O6-(2-chloroethyl)guanine mediates the biological effects of chloroethylnitrosoureas. | Environ Health Perspect | 1985 | https://conductscience.org/library/papers/4085418 | PubMed |
| 4056852 | Pharmacokinetics of 11C-BCNU in experimental brain tumor. | J Neurooncol | 1985 | https://conductscience.org/library/papers/4056852 | PubMed |
| 3903064 | Combination chemotherapy with cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) in children with brain tumors. | J Neurooncol | 1985 | https://conductscience.org/library/papers/3903064 | PubMed |
| 2937887 | Phase I clinical trial of intracarotid bis-chloroethylnitrosourea (BCNU) and 2' dioxy-5-fluorouridine (FUDR) in malignant astrocytomas. | J Neurooncol | 1986 | https://conductscience.org/library/papers/2937887 | PubMed |
| 2358844 | Chemosensitivity testing of human gliomas using a fluorescent microcarrier technique. | J Neurooncol | 1990 | https://conductscience.org/library/papers/2358844 | PubMed |
| 2319289 | Sensitivity of human malignant intracranial tumors against MCNU in vitro in comparison to ACNU and BCNU. | J Neurooncol | 1990 | https://conductscience.org/library/papers/2319289 | PubMed |
| 1848735 | Brain tumors. | West J Med | 1991 | https://conductscience.org/library/papers/1848735 | PubMed |
| 1744686 | Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy. | J Neurooncol | 1991 | https://conductscience.org/library/papers/1744686 | PubMed |
| 1643694 | Phase I study of BCNU and intravenous 6-mercaptopurine in patients with anaplastic gliomas. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1643694 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4334089
GET https://conductscience.org/api/papers/v1/4334089/cited_by?page=2